(Q63844693)

English

Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis

clinical trial

Statements

INSPIRE (English)
0 references
A Phase II Baseline Versus Treatment Study to Determine the Efficacy of Raltegravir (Isentress) in Preventing Progression of Relapsing Remitting Multiple Sclerosis as Determined by Gadolinium-enhanced MRI (English)
0 references
0 references
0 references
0 references
April 2013
0 references
September 2014
0 references
23
0 references
18 year
0 references
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit